Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 65,400 shares of the medical research company’s stock after selling 1,800 shares during the quarter. Grantham […]

Related Keywords

Washington ,United States ,Canada ,America ,Timothys Ernst ,Ajit Ramalingam ,Credit Suisse Group ,Grantham Mayo Van Otterloo Co ,Bio Rad Laboratories Inc ,Royal Bank ,Desjardins Global Asset Management Inc ,Ci Investments Inc ,Wells Fargo Company ,Exchange Commission ,Securities Exchange Commission ,Heritage Wealth Management ,Grantham Mayo Van Otterloo ,Bio Rad Laboratories ,Free Report ,Mayo Van Otterloo ,Wealth Management ,Global Asset Management ,Allworth Financial ,Rad Laboratories ,Get Free Report ,Suisse Group ,Life Science ,Clinical Diagnostics ,Visit Holdingschannel ,Bio Rad Laboratories Daily ,Nyse Bio ,Bio ,Medical ,09057220 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,